Search results for "NEP"

showing 10 items of 1924 documents

Hand-assisted laparoscopic living-donor nephrectomy versus open surgery: evaluation of surgical trauma and late graft function in 82 patients

2009

Abstract Objective We evaluated and quantified surgical trauma and late graft function in cases of hand-assisted laparoscopic living-donor nephrectomy (HALLDN) versus open living-donor nephrectom (OLDN). Methods This study is a retrospective nonrandomized single-center analysis. Between 1995 and January 2008, 82 patients with end-stage renal disease received kidney transplantations from living donors. Open living-donor nephrectomy was performed in 37 donors, and 45 underwent laparoscopic hand-assisted nephrectomy. Demographic data and perioperative and postoperative data, such as markers of acute phase (C-reactive protein; serum amyloid A) and biochemical markers of glomerular filtration (s…

AdultMaleRENAL-FUNCTIONmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentRenal functionNephrectomySettore MED/24 - UrologiaKIDNEYmedicineLiving DonorsHumansMinimally Invasive Surgical ProceduresCystatin CLaparoscopyKidney transplantationRetrospective StudiesCOMPLICATIONSOUTCOMESTransplantationSerum Amyloid A ProteinWarm Ischemia Timemedicine.diagnostic_testbusiness.industryPerioperativeMiddle Agedmedicine.diseaseKidney TransplantationNephrectomySurgeryEndoscopyTransplantationkidney transplantation laparoscopy nephrectomyC-Reactive ProteinRENAL-FUNCTION COMPLICATIONS EXPERIENCE OUTCOMES KIDNEY SAFETYSAFETYCreatinineEXPERIENCESurgeryFemaleLaparoscopybusinessImmunosuppressive AgentsGlomerular Filtration Rate
researchProduct

Vasopressin receptors involved in adrenergic neurotransmission in the circular muscle of the human vas deferens

1998

We studied the effects of vasopressin on the adrenergic responses of in vitro preparations of circular muscle from the vas deferens obtained from 28 men undergoing elective vasectomy. Vasopressin (3 x 10(-9)-3 x 10(-8) M) enhanced the phasic contractions elicited by electrical field stimulation and noradrenaline. This potentiation was blocked by the vasopressin V1 receptor antagonist d(CH2)5Tyr(Me)vasopressin (10(-6) M) but not by the vasopressin V2 receptor antagonist [d(CH2)5, D-Ile2,Ile4,Arg8]vasopressin (10(-6) M). The Ca2+ antagonist nifedipine (10(-6) M) did not affect the potentiation of electrical field stimulation induced by vasopressin and noradrenaline but reduced KCl-induced con…

AdultMaleReceptors Vasopressinmedicine.medical_specialtyVasopressinNifedipineVasopressinsNeuropeptideAdrenergicStimulationIn Vitro TechniquesSynaptic TransmissionPotassium ChlorideNorepinephrineHormone AntagonistsVas DeferensInternal medicinemedicineHumansVasoconstrictor AgentsVasopressin receptorPharmacologyArginine vasopressin receptor 1BChemistryAntagonistVas deferensMuscle SmoothCalcium Channel BlockersElectric StimulationArginine Vasopressinmedicine.anatomical_structureEndocrinologyAdrenergic alpha-AgonistsAntidiuretic Hormone Receptor Antagonistshormones hormone substitutes and hormone antagonistsMuscle ContractionEuropean Journal of Pharmacology
researchProduct

Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine

2002

It has been proposed that norepinephrine plays a critical role in the modulation of cortical excitability, which in turn is thought to influence functional recovery from brain lesions. The purpose of the present experiments was to determine if it is possible to modulate cortical excitability with the selective norepinephrine reuptake inhibitor reboxetine in intact humans. Recruitment curve and intracortical facilitation, assessed by transcranial magnetic stimulation, were increased after oral intake of 8 and 4 mg reboxetine, in the absence of changes in motor threshold, intracortical inhibition, M-response, F-wave or H-reflex. These results demonstrate that reboxetine enhances cortical exci…

AdultMaleRecruitment NeurophysiologicalMorpholinesmedicine.medical_treatmentCentral nervous systemNorepinephrine (medication)MagneticsReboxetinemedicineHumansNeurorehabilitationAdrenergic Uptake InhibitorsElectromyographyGeneral NeuroscienceReboxetineMotor CortexNeural InhibitionEvoked Potentials MotorTranscranial magnetic stimulationmedicine.anatomical_structureCatecholamineReuptake inhibitorPsychologyNeuroscienceMotor cortexmedicine.drugNeuroscience Letters
researchProduct

HDL subfractions distribution in renal transplant recipients: Lack of evidence of a reduction of HDL2 particles

1996

Since the high rate of cardiovascular disease in renal transplant recipients, alterations of lipoprotein profile in such patients were extensively evaluated, but the HDL subclass profile was not completely clarified. Renal transplant recipients usually show normal to high plasma levels of HDL cholesterol, even if some investigations suggested a persistence of low HDL2 levels: this was not useful in terms of cardiovascular protection. We designed this study in order to evaluate HDL subfractions distribution in renal transplant recipients. We studied 55 renal transplant recipients, treated with prednisone, azathioprine and/or cyclosporine, and 34 healthy normolipidemics as controls. In all su…

AdultMaleSettore MED/09 - Medicina InternaHDLCholesterol HDLMiddle AgedKidney TransplantationLipidsApolipoproteinsCardiovascular DiseasesRisk FactorsNephrologyMultivariate AnalysisRenal transplant recipientHumansFemaleKidney DiseasesLipoproteinAged
researchProduct

A longitudinal study of sleep disorders in early-stage chronic kidney disease

2010

Few studies have addressed the problem of sleep disturbances in patients with early-stage chronic kidney disease (CKD). A total of 220 patients newly diagnosed with CKD and 220 patients newly diagnosed with chronic hepatitis C were studied within 1 month from the diagnosis. They were evaluated by using the Charlson Comorbidity Index, the Pittsburgh Sleep Quality Index, and the Beck Depression Inventory. Patients with CKD were followed up for 4 years. Sleep disturbances affected 59.5% of patients with chronic hepatitis C and 84.6% of patients with CKD. Sleeping disorders that were severe and peculiar in early CKD improved significantly over time. Beck Depression Inventory disclosed significa…

AdultMaleSleep Wake Disordersmedicine.medical_specialtyLongitudinal studyMedicine (miscellaneous)Logistic regressionPittsburgh Sleep Quality IndexRenal DialysisInternal medicinemedicineHumansLongitudinal StudiesStage (cooking)Depression (differential diagnoses)AgedNutrition and DieteticsDepressionbusiness.industryBeck Depression InventoryHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseNephrologyChronic DiseasePhysical therapyFemaleKidney DiseasesbusinessGlomerular Filtration RateKidney disease
researchProduct

Blood pressure changes after automatic and fixed CPAP in obstructive sleep apnea. Relationship with nocturnal sympathetic activity.

2011

Treatment of obstructive sleep apnea (OSA) by continuous positive airway pressure (CPAP) usually causes a reduction in blood pressure (BP), but several factors may interfere with its effects. In addition, although a high sympathetic activity is considered a major contributor to increased BP in OSA, a relationship between changes in BP and in sympathetic nervous system activity after OSA treatment is uncertain. This study was undertaken to assess if, in OSA subjects under no pharmacologic treatment, treatment by CPAP applied at variable levels by an automatic device (APAP) may be followed by a BP reduction, and if that treatment is associated with parallel changes in BP and catecholamine exc…

AdultMaleSympathetic nervous systemSympathetic Nervous SystemAmbulatory blood pressurePhysiologymedicine.medical_treatmentambulatory blood pressure monitoring catecholaminesBlood PressureSettore MED/10 - Malattie Dell'Apparato RespiratorioNorepinephrineCatecholaminesInternal MedicinemedicineHumansContinuous positive airway pressureWakefulnessSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industrySleep apneaGeneral MedicineBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseCircadian RhythmNormetanephrinenervous system diseasesrespiratory tract diseasesObstructive sleep apneamedicine.anatomical_structureBlood pressureAnesthesiaAmbulatoryCatecholamineSleepbusinessmedicine.drug
researchProduct

Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephrit…

2008

Objectives:To evaluate the role of immunological tests for monitoring lupus nephritis (LN) activity.Methods:C3, C4, anti-dsDNA and anti-C1q antibodies were prospectively performed over 6 years in 228 patients with LN.Results:In membranous LN only anti-C1q antibodies differentiated proteinuric flares from quiescent disease (p = 0.02). However, in this group 46% of flares occurred with a normal value of anti-C1q antibodies versus 20% in proliferative LN (p = 0.02). In patients with antiphospholipid antibodies (APL), 33% of flares occurred with normal levels of anti-C1q antibodies versus 14.5% in patients that were APL-negative (p = 0.02). In proliferative LN, anti-C1q antibodies showed a slig…

AdultMaleSystemic diseasemedicine.medical_specialtyImmunologyLupus nephritisGastroenterologySeverity of Illness IndexGeneral Biochemistry Genetics and Molecular BiologyYoung AdultRheumatologyimmune system diseasesInternal medicineImmunopathologyMedicineHumansImmunology and Allergyskin and connective tissue diseasesProspective cohort studyAutoantibodiesUnivariate analysisBiochemistry Genetics and Molecular Biology (all)business.industryComplement C1qComplement C4BiomarkerComplement C3DNALupus NephritiMiddle Agedmedicine.diseaseConnective tissue diseaseLupus NephritisAutoantibodieRheumatologyAntibodies AntinuclearImmunologyEpidemiologic MethodFemalebusinessEpidemiologic MethodsBiomarkersKidney diseaseHuman
researchProduct

Trends and Prevalence of Nocturia Among US Adults, 2005-2016

2019

Purpose: Increased nocturia episodes can be a clinical marker of poor health status. The present study aimed to evaluate patterns and temporal trends in nocturia and sociodemographic and lifestyle correlates in the US population. Methods: Participants, aged 20 years or older, were included in this repeated cross-sectional study. The National Health and Nutrition Examination Survey from 2005 to 2016 was used. Participants were asked “During the past 30 days, how many times per night did you most typically get up to urinate, from the time you went to bed at night until the time you got up in the morning?”. Individuals were categorized as either ≥ 1 nocturia episode or ≥ 2 nocturia episodes pe…

AdultMaleTime FactorsNational Health and Nutrition Examination SurveyUrologymedia_common.quotation_subjectPopulation030232 urology & nephrologyClinical marker030204 cardiovascular system & hematologyUrination03 medical and health sciencesYoung AdultSoysal P. Cao C. Xu T. Yang L. Isik A. Turan K. Liu Q. Pizzol D. Veronese N. Demurtas J. et al. -Trends and prevalence of nocturia among US adults 2005-2016.- International urology and nephrology 20190302 clinical medicineAge groupsPrevalenceMedicineNocturiaHumanseducationNocturia · Trend · United States · NHANESMorningmedia_commoneducation.field_of_studybusiness.industryMiddle AgedUnited StatesSecular variationCross-Sectional StudiesNephrologyFemaleNocturiamedicine.symptombusinessDemography
researchProduct

EchoScopy in scanning abdominal diseases: initial clinical experience.

2014

Background and Aims: The introduction of a new type of small handheld ultrasound device brings greater portability and affordability. The basic ultrasound approach with these handheld devices has been defined by European Federation of Societies of Ultrasound in Medicine and Biology (EFSUMB) as “EchoScopy”. The current study aimed to assess the image quality, indications and limitations of a portable pocket “EchoScope” compared with a high-end ultrasound system in abdominal diseases. Methods: 231 consecutive patients were included in this study. Physician A performed ultrasound examinations with a high-end ultrasound system (HEUS), then physician B performed the same ultrasound examination u…

AdultMaleUrologic Diseasesmedicine.medical_specialtyAdolescentImage qualityDigestive System DiseasesPilot ProjectsEndocrine System DiseasesSensitivity and SpecificityLesionYoung AdultVascularityAscitesAbdomenMedicineHumansUltrasonography Doppler ColorProspective cohort studyChildPathologicalHydronephrosisAgedAged 80 and overMiniaturizationbusiness.industryUltrasoundGastroenterologyReproducibility of ResultsEquipment DesignMiddle Agedmedicine.diseaseEquipment Failure AnalysisCardiovascular DiseasesFemaleRadiologymedicine.symptombusinessZeitschrift fur Gastroenterologie
researchProduct

Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment

2018

Abstract Background Autonomic nervous system dysfunction, common in patients with Parkinson’s disease (PD), causes significant morbidity and it is correlated with poor quality of life. To assess frequency of urinary symptoms in patients with PD, without conditions known to interfere with urinary function. Methods Non-demented PD patients were consecutively enrolled from the outpatients clinic of our department. Scales investigating motor and non-motor symptoms were carried out. Evaluation of urinary dysfunctions was carried out using the AUTonomic Scale for Outcomes in Parkinson’s disease (SCOPA-AUT) questionnaire. Patients underwent noninvasive urological studies (nUS), including uroflowme…

AdultMaleUrologic Diseasesmedicine.medical_specialtyNeurologyParkinson's diseaseUrinary systemAutonomic dysfunction030232 urology & nephrologyNon-motor symptomsUrinary symptomsDiseaseNon-motor symptomlcsh:RC346-429SCOPA-AUT03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesInternal medicinemedicineHumansNeurochemistryStage (cooking)lcsh:Neurology. Diseases of the nervous systemAgedbusiness.industryAUTonomic SCale for outcomes in Parkinson’s diseaseParkinson DiseaseGeneral MedicineMiddle AgedUrinary functionmedicine.diseaseAutonomic Nervous System DiseasesQuality of LifeParkinson’s diseaseFemaleSettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusiness030217 neurology & neurosurgeryBMC Neurology
researchProduct